Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
22
Cancer patients don't have time to waste, yet many must endure a tedious process of elimination as physicians try several different treatments until identifying the one that is most effective against their particular type of tumor. Now researchers at the University of Virginia Health System have developed a breakthrough method that could one day eliminate this trial and error approach to treating many cancers.
20
Exercise may protect against both memory-loss and depressive mood after whole-brain radiation treatments, U.S. researchers say. The study, presented at the Society for Neuroscience annual meeting in Chicago, found mice with access to an exercise wheel less likely to suffer a decline in erasable memory after radiation and less likely to show depressive-like behavior.
Decades of studies have documented the link between eating a diet rich in vegetables and multiple health benefits, yet nearly eight out of 10 people worldwide fall short of the daily recommendation.(1) Research presented at the International Symposium on Human Health Effects of Fruits and Vegetables suggests the best approach may be to focus on the factors that are often behind this vegetable gap: convenience and enjoyment.
Warfarin, one of the most inconvenient, dangerous, and disliked drugs in the world, has remained vitally important for more than 50 years. That tells you how much difficulty scientists have had coming up with safer, easier pills to do what warfarin does -- fight life- threatening blood clots.
19
The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005. Votrient is an oral medication that interferes with angiogenesis, the growth of new blood vessels needed for solid tumors to grow and survive.
Today, Lung Cancer Alliance (LCA) announced the launch of the Shine a Light National Lung Cancer Vigil, a campaign designed to raise awareness of lung cancer during November, Lung Cancer Awareness Month. Building on the success of vigils held across the country over the past three years, LCA is encouraging an even greater number of volunteers to host a vigil in their community.
16
NCCN program on Discovery Health Channel profiles patients battling advanced non-small cell lung cancer and highlights their physicians' use of the NCCN Guidelines for Non- Small Cell Lung Cancer in determining the best treatment regimen. The program, which provides free CME credits, premieres on Sunday, October 18 at 7:00 am EDT.
15
Researchers at Henry Ford Hospital have identified tumor-suppressing genes that may provide a more accurate diagnosis of disease stage and survival for laryngeal cancer patients than current standards. The study finds genetic abnormalities of the ESR1(estrogen specific receptor 1) gene and the HIC1 (hypermethylated in cancer 1) gene are predictors of late-stage laryngeal cancer and shorter survival, respectively, for patients with the disease.
Data detailed in 'Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case- control studies' have been presented. Although cigarette smoking and alcohol consumption increase risk for head and neck cancers, there have been few attempts to model risks quantitatively and to formally evaluate cancer site-specific risks.
New research integrates sophisticated interdisciplinary approaches to solve a molecular mystery that may lead to alternative therapeutic strategies for acute myeloid leukemia (AML). The study, published by Cell Press in the October issue of the journal Cancer Cell, identifies a previously unrecognized AML target that responds well to pharmacological inhibition and may be an excellent candidate for use in future clinical trials.
We care about your feedback. Let us know how we can improve your CancerCompass experience.